AI Maverick Intel Inc. (OTC: AIMV), a Delaware corporation focused on applying artificial intelligence and data technologies to healthcare, announced the appointment of Dr. Wayne Young, BSc, DDS, to its Board of Directors. The appointment comes as the company advances a definitive agreement to acquire 100% of the issued and outstanding shares of HEAL Access Canada Inc. from HEAL Group Holdings Inc., subject to certain closing conditions.
Dr. Young brings more than three decades of experience spanning healthcare, clinical practice, business, and leadership. His addition to the board is expected to provide valuable guidance as AI Maverick Intel seeks to establish HEAL Access as the foundation of its operating strategy in AI-enabled healthcare. The company believes that Young’s deep industry knowledge will be instrumental in navigating the complexities of integrating AI into real-world healthcare solutions.
The acquisition of HEAL Access is a key component of AI Maverick Intel’s broader vision to build and grow operating businesses that leverage artificial intelligence and data technologies. By acquiring HEAL Access, the company intends to create a platform that can address pressing healthcare needs through innovative AI applications. The transaction remains subject to closing conditions, and further details are expected as the deal progresses.
In a separate development, AI Maverick Intel announced a settlement with Stronghold Media Group Corp. Under the agreement, the parties mutually rescinded their August 2024 transaction and resolved their respective obligations. As part of the settlement, the associated intellectual property has been reassigned to Stronghold Group. This resolution allows AI Maverick Intel to focus on its core strategy without the burden of previous obligations.
Additionally, the company is planning a corporate name change and expects to announce a new name and identity following the completion of necessary corporate and regulatory processes. This rebranding is part of a broader corporate transition that aligns with its evolving focus on AI-driven healthcare.
The implications of these announcements are significant for investors and the healthcare industry. AI Maverick Intel’s move to strengthen its board with a seasoned healthcare professional and to acquire HEAL Access demonstrates a clear commitment to becoming a serious player in the AI healthcare space. If successful, the acquisition could position the company to develop and commercialize AI solutions that improve patient outcomes and operational efficiencies in healthcare settings.
For those following the company, the latest news and updates are available in its newsroom. NetworkNewsWire, a specialized communications platform, has been covering the developments, and the full press release can be viewed through https://nnw.fm/dtv7m. NetworkNewsWire is part of the Dynamic Brand Portfolio at IBN, which offers a range of services including InvestorWire for wire distribution, editorial syndication to 5,000+ outlets, and social media distribution to millions of followers. These channels help companies like AI Maverick Intel reach a wide audience of investors and industry participants.
As AI Maverick Intel continues its transition, stakeholders will be watching closely to see how the acquisition of HEAL Access and the upcoming rebranding unfold. The company’s ability to execute on its strategy could have broader implications for the adoption of AI in healthcare, potentially setting a precedent for how technology and data can be harnessed to address complex medical challenges.
